Overview
- 19 inspections across 19 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-09-26.
At a glance
Inspections
19
Sites
19
Observations
30
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Eugia Pharma Specialities Limited | 26 Sep 2014 | Human Drugs | On file |
| Zydus Hospira Oncology Private Limited | 16 Sep 2014 | Human Drugs | |
| Sanofi-Aventis Deutschland GmbH | 2 Jul 2013 | Human Drugs | On file |
| Public Health England | 8 Mar 2013 | Human Drugs | View 483 → |
| Fareva Pau | 26 Feb 2013 | Human Drugs | View 483 → |
Sites inspected
Eugia Pharma Specialities LimitedSangareddy, India1 insp.
Zydus Hospira Oncology Private LimitedMatoda, India1 insp.
Sanofi-Aventis Deutschland GmbHFrankfurt Am Main, Germany1 insp.
Public Health EnglandSalisbury, United Kingdom1 insp.
Fareva PauIdron, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Regina T Brown5 shared
Nebil A Oumer2 shared
Julianne C Mccullough2 shared
Marie F Morin2 shared
Neil J Bonzagni2 shared
Kristy A Zielny2 shared
Sandra A Hughes1 shared
Michelle J Glembin1 shared
Robert J Martin1 shared
Atul Agrawal1 shared
Full investigator report
Get the verbatim findings behind Barbara D Paul's 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site